Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Clean interim safety review of RhoVac's clinical phase IIb study in prostate cancer

prnasiaJuly 12, 2021

Tag: BRaVac , RhoVac , RV001 , Prostate Cancer

PharmaSources Customer Service